Oncaspar OverviewPegaspargase, sold under the trade name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). Often it is used together with anthracycline, vincristine, and prednisone. It is used by injection. Common side effects include allergic reactions, blood clotting problems, high blood sugar, liver problems, pancreas inflammation, and blood clots in the brain. Its use during pregnancy may harm ...
Read more Oncaspar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegaspargase
Recent Oncaspar Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 750IU/ml
- Vial: 750iu/vial
NDC Database Records for Oncaspar: (3 results)Sorted by National Drug Code
- 0944-3810 Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, Solution by Baxalta Us Inc.
- 54482-301 Oncaspar 750 [iu]/Ml Intramuscular; Intravenous Injection, Solution by Sigma-tau Pharmaceuticals, Inc.
- 72694-954 Oncaspar 750 [Iu]/Ml Intramuscular; Intravenous Injection, Solution by Servier Pharmaceuticals